Back to top
more

Chemours (CC)

(Delayed Data from NYSE)

$20.80 USD

20.80
2,046,669

+2.11 (11.29%)

Updated Sep 26, 2024 04:00 PM ET

After-Market: $20.79 -0.01 (-0.05%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

5-Strong Sell of 5         5

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

D Value F Growth B Momentum F VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 25% (190 out of 252)

Industry: Chemical - Diversified

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

FMC Corp (FMC) to Post Q1 Earnings: What's in the Cards?

by Zacks Equity Research

FMC Corp's (FMC) first-quarter performance is likely to reflect increased demand and pricing amid headwinds from higher input costs resulting from supply chain disruptions.

Westlake (WLK) to Post Q1 Earnings: What's in the Cards?

by Zacks Equity Research

Westlake's (WLK) Q1 performance is likely to have benefited from higher demand trends for polyethylene and PVC resin.

Will Higher Selling Prices Drive Mosaic's (MOS) Q1 Earnings?

by Zacks Equity Research

Profitability across Mosaic's (MOS) Phosphates and Potash segments is expected to have boosted by higher average selling prices in Q1.

Intrepid Potash (IPI) to Post Q1 Earnings: What's in the Offing?

by Zacks Equity Research

Intrepid Potash (IPI) is likely to have benefited from strong demand and higher net realized sales price per ton for its potash and Trio products in Q1.

Nutrien (NTR) to Report Q1 Earnings: What's in the Cards?

by Zacks Equity Research

Nutrien's (NTR) Q1 results are likely to have benefited from solid demand and higher prices for fertilizers, aided by the underlying strength in global agriculture markets.

Chemours (CC) Outpaces Stock Market Gains: What You Should Know

by Zacks Equity Research

In the latest trading session, Chemours (CC) closed at $32.64, marking a +1.15% move from the previous day.

LyondellBasell (LYB) to Post Q1 Earnings: What's in the Cards?

by Zacks Equity Research

LyondellBasell's (LYB) Q1 performance is likely to have benefited from strong consumer-driven demand and favorable market trends.

Chemours (CC) to Post Q1 Earnings: What's in the Cards?

by Zacks Equity Research

Chemours' (CC) first-quarter performance is likely to reflect the increasing adoption of Opteon refrigerants and the benefits of cost-cutting measures.

Mosaic (MOS) to Report Q1 Earnings: What's in the Cards?

by Zacks Equity Research

Mosaic (MOS) is likely to have benefited from strong demand and prices for phosphate and potash in the first quarter.

Huntsman (HUN) to Report Q1 Earnings: What's in the Cards?

by Zacks Equity Research

Huntsman's (HUN) Q1 performance is likely to have benefited from health demand and prices for MDI amid headwinds from higher input and logistics costs.

Celanese (CE) to Report Q1 Earnings: What's in the Offing?

by Zacks Equity Research

Celanese's (CE) Q1 performance is likely to have benefited from productivity actions, investments in high-return organic projects and strategic acquisitions.

Linde (LIN) Gears Up to Post Q1 Earnings: What's in Store?

by Zacks Equity Research

Higher industrial production is likely to have aided Linde (LIN) in Q1.

Chemours (CC) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

by Zacks Equity Research

Chemours (CC) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Chemours (CC) Gains As Market Dips: What You Should Know

by Zacks Equity Research

Chemours (CC) closed at $35.65 in the latest trading session, marking a +0.85% move from the prior day.

Chemours (CC) Gains As Market Dips: What You Should Know

by Zacks Equity Research

Chemours (CC) closed at $32.44 in the latest trading session, marking a +0.43% move from the prior day.

Northern Technologies (NTIC) Q2 Earnings and Revenues Lag Estimates

by Zacks Equity Research

Northern Technologies (NTIC) delivered earnings and revenue surprises of -33.33% and 4.84%, respectively, for the quarter ended February 2022. Do the numbers hold clues to what lies ahead for the stock?

Chemours (CC) Gains But Lags Market: What You Should Know

by Zacks Equity Research

Chemours (CC) closed at $32.32 in the latest trading session, marking a +0.19% move from the prior day.

Chemours (CC) is a Top-Ranked Growth Stock: Should You Buy?

by Zacks Equity Research

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Chemours (CC) Outpaces Stock Market Gains: What You Should Know

by Zacks Equity Research

Chemours (CC) closed the most recent trading day at $32.18, moving +1.71% from the previous trading session.

Chemours (CC) is a Top-Ranked Value Stock: Should You Buy?

by Zacks Equity Research

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Chemours (CC) Gains As Market Dips: What You Should Know

by Zacks Equity Research

Chemours (CC) closed at $30.55 in the latest trading session, marking a +0.03% move from the prior day.

Chemours (CC) Gains But Lags Market: What You Should Know

by Zacks Equity Research

Chemours (CC) closed the most recent trading day at $29.17, moving +1.14% from the previous trading session.

Chemours (CC) Gains As Market Dips: What You Should Know

by Zacks Equity Research

In the latest trading session, Chemours (CC) closed at $25.88, marking a +1.61% move from the previous day.

Chemours (CC) is a Top-Ranked Growth Stock: Should You Buy?

by Zacks Equity Research

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Chemours (CC) Earnings Miss Estimates, Revenues Top in Q4

by Zacks Equity Research

Volumes and prices contributed favorably to Chemours' (CC) top-line growth in the fourth quarter. It sees adjusted earnings per share in the band of $4.07-$4.70 for 2022.